Publikationen von R. Hohlfeld

Farina, C.; Wagenpfeil, S.; Hohlfeld, R.: Immunological assay for assessing the efficacy of glatiramer acetate (Copaxone) in multiple sclerosis - A pilot study. Journal of Neurology 249 (11), S. 1587 - 1592 (2002)

Hohlfeld, R.: Myelin failure in multiple sclerosis: Breaking the spell of Notch. Nature Medicine 8 (10), S. 1075 - 1076 (2002)

Hohlfeld, R.: How promising is hematopoetic stem cell transplantation in multiple sclerosis? J Neurol. 249, S. 1147 - 1149 (2002)

Meinl, E.; Hohlfeld, R.: Immunopathogenesis of multiple sclerosis: MBP and beyond. Clinical and Experimental Immunology 128 (3), S. 395 - 397 (2002)

Scolding, N. J.; Wilson, H.; Hohlfeld, R.; Polman, C.; Leite, I.; Gilhus, N.; The EFNS Crebral Vasculitis Task Force: The recognition, diagnosis and management of cerebral vasculitis: A European survey. European Journal of Neurology 9 (4), S. 343 - 347 (2002)

Stadelmann, C.; Kerschensteiner, M.; Misgeld, T.; Bruck, W.; Hohlfeld, R.; Lassmann, H.: BDNF and gp145trkB in multiple sclerosis brain lesions: Neuroprotective interactions between immune and neuronal cells? Brain 125, S. 75 - 85 (2002)

Wiendl, H.; Hohlfeld, R.: Therapeutic approaches in multiple sclerosis - Lessons from failed and interrupted treatment trials. Biodrugs 16 (3), S. 183 - 200 (2002)

Wiendl, H.; Malotka, J.; Holzwarth, B.; Weltzien, H. U.; Wekerle, H.; Hohlfeld, R.; Dornmair, K.: An autoreactive gamma delta TCR derived from a polymyositis lesion. Journal of Immunology 169 (1), S. 515 - 521 (2002)

Ziemssen, T.; Kümpfel, T.; Klinkert, W. E. F.; Neuhaus, O.; Hohlfeld, R.: Glatiramer acetate-specific T-helper 1-and 2-type cell lines produce BDNF: Implications for multiple sclerosis therapy. Brain 125, S. 2381 - 2391 (2002)

Ziemssen, T.; Neuhaus, O.; Farina, C.; Hartung, H. P.; Hohlfeld, R.: Treatment of multiple sclerosis with glatiramer acetate - new information about its mechanisms of action, pharmacokinetics, adverse effects and clinical studies. Nervenarzt 73 (4), S. 321 - 331 (2002)

Ziemssen, T.; Neuhaus, O.; Hohlfeld, R.: Risk-benefit assessment of glatiramer acetate in multiple sclerosis. Drug Safety 24 (13), S. 979 - 990 (2002)

Farina, C.; Bergh, F. T.; Albrecht, H.; Meinl, E.; Yassouridis, A.; Neuhaus, O.; Hohlfeld, R.: Treatment of multiple sclerosis with Copaxone (COP) Elispot assay detects COP-induced interleukin-4 and interferon-gamma response in blood cells. Brain 124, S. 705 - 719 (2001)

Hohlfeld, R.; Kerschensteiner, M.; Stadelmann, C.; Lassmann, H.; Wekerle, H.: The neuroprotective effect of inflammation: Implications for the therapy of multiple sclerosis. Journal of Neuroimmunology 107 (2), S. 161 - 166 (2000)

Meinl, E.; Hohlfeld, R.: T cell transformation with Herpesvirus saimiri: A tool for neuroimmunological research. Journal of Neuroimmunology 103 (1), S. 1 - 7 (2000)

Haase, C. G.; Hohlfeld, R.: Knochenmark- und Stammzelltransplantation bei multipler Sklerose? Nervenarzt 70 (2), S. 178 - 181 (1999)

Hohlfeld, R.: Therapeutic strategies in multiple sclerosis. I. Immunotherapy. Philosophical Transactions of the Royal Society of London, Series B: Biological Sciences 354 (1390), S. 1697 - 1710 (1999)

Kerschensteiner, M.; Gallmeier, E.; Behrens, L.; Vargas-Leal, V.; Misgeld, T.; Klinkert, W. E. F.; Kolbeck, R.; Hoppe, E.; Oropeza-Wekerle, R. L.; Bartke, I. et al.; Stadelmann, C.; Lassmann, H.; Wekerle, H.; Hohlfeld, R.: Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: A neuroprotective role of inflammation? Journal of Experimental Medicine 189 (5), S. 865 - 870 (1999)

Behrens, L.; Kerschensteiner, M.; Misgeld, T.; Goebels, N.; Wekerle, H.; Hohlfeld, R.: Human muscle cells express a functional costimulatory molecule distinct from B7,1 (CD80) and B7,2 (CD86) in vitro and in inflammatory lesions. Journal of Immunology 161 (11), S. 5943 - 5951 (1998)

Dang, T.; Goebels, N.; Walther, E. U.; Hohlfeld, R.: Treatment of relapsing-remitting multiple sclerosis with copolymer-1 (Glatirameracetate). Aktuelle Neurologie 25 (4), S. 159 - 164 (1998)

Bradl, M.; Dornmair, K.; Hohlfeld, R.: New tools for investigating the immunopathogenesis of MS: Principles and applications. In: Multiple Sclerosis: A Comprehensive Text, S. 284 - 299 (Hg. Raine, C. S.; McFarland, H. F.; Hohlfeld, R.). Saunders, Elsevier, Edinburgh (2008)

Hohlfeld, R.; Wekerle, H.: Novel therapeutic approaches to autoimmunity. In: Autoimmune Diseases, 3 Aufl., S. 833 - 847 (Hg. Rose, N. R.; Mackay, I. R.). Academic Press, San Diego, Calif. (1998)